Traduction / Translation: Français
Finding a study
According to a recent study lead by ResearchersAgainstAlzheimer’s (RA2) the number of clinical trials evaluating possible treatments against Alzheimer’s disease is on the rise. The results of this study called « Where are we on the path 2025 » were presented at UsAgaintsAlzheimer summit held in Washington D.C last September.
To date 57 clinical trials are either in phase II or III, with 19 promising molecules that could reach the market within 5 years. It’s very encouraging to see that the number of phase II tested drugs is so important, with various therapeutic approach, which give us a real hope in the future.
With this new challenge, patient recruitment is more important than ever. We have a duty to help them make the best choice for themselves and their loved ones by knowing all the advantages of being involved in a study but also evaluating potential risks related to clinical trials.
The Federation of Quebec Alzheimer Societies decided to support several research initiatives:
- Research studies at the Stop-AD Centre of the Douglas Institute (brochure)
- The development of a cognitive screening test at the interdisciplinary memory clinic of CHU-Quebec
- The CCNA COMPASS-ND study (national study with 2 recruitment centre in Quebec)
- How to get free and at home dental examination? Laval University (in French only)
- New study on brothers ans sisters caring for parents with dementia – University of Toronto.
To know more about ongoing clinical trials in Quebec and in Canada, here are useful links:
- Clinical Trial simplified: Their mission is to help every patient find a clinical trial that matches his medical condition. Several studies are already recruiting!
The Federation Quebec of Alzheimer Societies would like to acknowledge the support of Eli Lilly Canada and Merck Canada for making this document possible. The opinions expressed herein are those of the authors and do not reflect the point of view of the partners.